Olympus 2015 Annual Report Download - page 57

32. Related-Party Transactions
(1) Related-party transactions
There were no related-party transactions to be disclosed for the years ended March 31, 2014 and 2015.
(2) Note about significant related party
A summary of financial statements regarding all affiliated companies accounted for by the equity method, including Sony Olympus Medical
Solutions Inc., for the year ended March 31, 2015 was as follows:
Millions of yen
Thousands of
U.S. dollars
2015 2015
Total current assets............................................................................................................................................................. ¥17,666 $147,217
Total non-current assets ..................................................................................................................................................... 3,453 28,775
Total current liabilities .......................................................................................................................................................... 15,738 131,150
Total non-current liabilities ................................................................................................................................................... 3,726 31,050
Total net assets................................................................................................................................................................... 1,655 13,792
Net sales ............................................................................................................................................................................ 33,609 280,075
Loss before income taxes ................................................................................................................................................... (4,352) (36,267)
Net loss .............................................................................................................................................................................. (5,108) (42,567)
33. Business Combinations
There were no material business combinations to be disclosed during the years ended March 31, 2014 and 2015.
34. Subsequent Events
(1) Transactions under Common Control
On April 1, 2015, the Company succeeded to the medical systems business of its wholly owned subsidiary Olympus Medical Systems Corp.
(except for part of the manufacturing functions and part of the functions for responding to the laws and regulations for medical devices in the
operating countries) based on an absorption-type company split, and merged its wholly owned subsidiary Olympus Imaging Corp. based on
an absorption-type merger. In addition to the above reorganization, the Company also conducted an absorption-type merger with its wholly
owned subsidiary Olympus Intellectual Property Services Co., Ltd. These actions were in accordance with resolutions of a Board of
Directors’ meeting held on December 19, 2014.
1. Overview of transactions
(1) Absorption-type company split
(i) Name and description of business involved in combination
Name of business Medical systems business
Description of business Manufacture and sales of medical endoscopes and other medical devices (except for part of the
manufacturing functions and part of the functions for responding to the laws and regulations for
medical devices in the operating countries)
Total assets ¥143,544 million ($1,196,200 thousand)
Liabilities ¥106,397 million ($886,642 thousand)
Net assets ¥37,147 million ($309,558 thousand)
(ii) Date of business combination
April 1, 2015
(iii) Legal form of business combination
Absorption-type company split in which Olympus Medical Systems Corp. becomes a splitting company and the Company
becomes a succeeding company
(iv) Name of company after combination
Olympus Corporation
(e) Outstanding balances of goodwill by reportable segment as of March 31, 2014 and 2015 were as follows:
Millions of yen
2014
Medical
Scientific
Solutions Imaging Others
Consolidated
Total
Outstanding balance of goodwill ............................................................... ¥103,745 ¥3,005 ¥— ¥100 ¥106,850
Millions of yen
2015
Medical
Scientific
Solutions Imaging Others
Consolidated
Total
Outstanding balance of goodwill .............................................................. ¥111,205 ¥2,749 ¥— ¥71 ¥114,025
Thousands of U.S. dollars
2015
Medical
Scientific
Solutions Imaging Others
Consolidated
Total
Outstanding balance of goodwill .............................................................. $926,708 $22,908 $— $592 $950,208
(f) Amortization of negative goodwill by reportable segment
There was no amortization of negative goodwill for the years ended March 31, 2014 and 2015.
31. Amounts per Share
Net income (loss) per share is computed by dividing income available to common shareholders by the average number of common shares
outstanding for each fiscal year. Diluted income (loss) per share is similar to basic net income per share except that the average of common
shares outstanding is increased by the number of additional common shares that would have been outstanding if the potentially dilutive
common shares had been issued. For the year ended March 31 2015, although there were dilutive potential common shares, diluted net
income per share was not presented due to the recording of a net loss.
Net assets per share are computed based on the net assets excluding share subscription rights and minority interests and the number of
shares of common stock outstanding at the year-end.
For the years ended March31 Yen U.S. dollars
2014 2015 2015
Net income (loss):
Basic .............................................................................................................................................. ¥41.05 ¥(25.53) $(0.213)
Diluted ............................................................................................................................................ 41.04 — —
As of March31 Yen U.S. dollars
2014 2015 2015
Net assets ............................................................................................................................................. ¥962.83 ¥1,038.64 $8.655
The basis for calculation are as follows:
(1) Basic and diluted net income (loss) per share
For the years ended March31 Number of shares
2014 2015
Average number of shares for basic net income ................................................................................................................. 331,992,635 342,238,820
(2) Net assets per share
As of March31 Number of shares
2014 2015
Number of shares of common stock used for the calculation of net assets per share ......................................................... 342,240,445 342,237,272
As of March31 Millions of yen
Thousands of
U.S. dollars
2014 2015 2015
Total net assets...................................................................................................................................... ¥331,284 ¥357,254 $2,977,117
Amounts deducted from total net assets:
Stock acquisition rights ...................................................................................................................... 115 260 2,167
Minority interests ................................................................................................................................ 1,650 1,532 12,767
Net assets attributable to shares of common stock ............................................................................... ¥329,519 ¥355,462 $2,962,183
Notes to the Consolidated Financial Statements
111
OLYMPUS Annual Report 2015
110 OLYMPUS Annual Report 2015